A silent outbreak due to Klebsiella pneumoniae that co-produced NDM-1 and OXA-48 carbapenemases, and infection control measures
暂无分享,去创建一个
[1] M. Parlak,et al. Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance. , 2018, Microbial drug resistance.
[2] R. Wunderink,et al. Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials , 2017, Open forum infectious diseases.
[3] Young Bae Kim,et al. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods , 2016, Front. Microbiol..
[4] W. Hryniewicz,et al. Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[5] J. Lavigne,et al. Environmental persistence of OXA-48-producing Klebsiella pneumoniae in a French intensive care unit. , 2016, American journal of infection control.
[6] A. Kilic,et al. The First Klebsiella pneumoniae Isolate Co-Producing OXA-48 and NDM-1 in Turkey , 2015, Annals of laboratory medicine.
[7] B. Wiedenmann,et al. An outbreak of carbapenem-resistant OXA-48 – producing Klebsiella pneumonia associated to duodenoscopy , 2015, Antimicrobial Resistance and Infection Control.
[8] P. Nordmann,et al. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[9] S. Solomon,et al. Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.
[10] D. Raoult,et al. New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[11] P. Nordmann,et al. Spread of NDM-1-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Istanbul, Turkey , 2014, Antimicrobial Agents and Chemotherapy.
[12] M. Timinouni,et al. First report of a Klebsiella pneumoniae strain coproducing NDM‐1, VIM‐1 and OXA‐48 carbapenemases isolated in Morocco , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[13] M. Bassetti,et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] R. Widen,et al. Rapid detection of carbapenemase genes by multiplex real-time PCR. , 2012, The Journal of antimicrobial chemotherapy.
[15] Thierry Naas,et al. Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.
[16] Clinical,et al. Performance standard for antimicrobial susceptibility testing. , 2010 .
[17] A. Tekeli,et al. [Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae strains isolated between 2004-2007 in Ankara University Hospital, Turkey]. , 2010, Mikrobiyoloji bulteni.
[18] B. Otlu,et al. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. , 2009, Japanese journal of infectious diseases.
[19] Iraida E. Robledo,et al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. , 2009, MMWR. Morbidity and mortality weekly report.
[20] P. Nordmann,et al. Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey , 2008, Antimicrobial Agents and Chemotherapy.
[21] Z. Aktaş,et al. Carbapenem-Hydrolyzing Oxacillinase, OXA-48, Persists in Klebsiella pneumoniae in Istanbul, Turkey , 2008, Chemotherapy.
[22] F. Biscione,et al. A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. , 2007, American journal of infection control.
[23] N. Woodford,et al. Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. , 2006, The Journal of antimicrobial chemotherapy.
[24] P. Nordmann,et al. Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae , 2004, Antimicrobial Agents and Chemotherapy.